Furthermore, many studies have demonstrated that a number of drugs and chemicals exert anti-tumor effects by upregulating SESN2, including but not limited to 5-fluorouracil [33], oxaliplatin [51], nelfinavir, and bortezomib [52]. The gene discussed is SESN2; the disease is neoplasm.